Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR
Hongyu Zhao,
Wei Tian,
Cynthia Tai, and
David M. Cohen
Division of Nephrology and Hypertension, Oregon Health and Science
University and the Portland Veterans Affairs Medical Center, Portland, Oregon
97201
Submitted 21 January 2003
; accepted in final form 30 March 2003
 |
ABSTRACT
|
---|
Hypertonic stress increases expression of cyclooxygenase-2 (COX-2) in renal
medullary epithelial and interstitial cells. Because hypertonic COX-2
expression is, in part, sensitive to inhibition of the ERK MAPK, an effector
of activated receptor tyrosine kinases such as the EGF receptor, we
investigated a role for this receptor in signaling to COX-2 expression.
Hypertonic stress increased COX-2 expression at the mRNA and protein levels at
6 and 24 h of hypertonic treatment. Two potent, specific inhibitors of the EGF
receptor kinase, AG-1478 and PD-153035, abrogated this effect. These
inhibitors also blocked the ability of hypertonic stress to increase
PGE2 release; in addition, they partially blocked
tonicity-dependent phosphorylation of ERK but not of the related MAPKs, JNK or
p38. Pharmacological inhibition of ERK activation partially blocked
tonicity-dependent COX-2 expression. Hypertonic induction of COX-2 was likely
transcriptionally mediated, as NaCl stress increased luciferase reporter gene
activity under control of the human COX-2 promoter, and this effect was also
sensitive to inhibition of the EGF receptor kinase. Metalloproteinase action
is required for transactivation of the EGF receptor. Pharmacological
inhibition of metalloproteinase function blocked tonicity-inducible COX-2
expression. Furthermore, the effect of hypertonicity on COX-2 expression was
also evident in the EGF-responsive Madin-Darby canine kidney and 3T3 cell
lines but was virtually absent from the EGF-unresponsive (and EGF receptor
null) Chinese hamster-derived CHO cell line. Taken together, these data
indicate that hypertonicity-dependent COX-2 expression in medullary epithelial
cells requires transactivation of the EGF receptor and, potentially,
ectodomain cleavage of an EGF receptor ligand.
hypertonicity; heparin-binding epidermal growth factor; kidney; cylooxygenase
HYPERTONICITY IS A fundamental, phylogenetically ubiquitous
environmental stressor. In mammals, few tissues are exposed to wide ranges of
ambient tonicity; one exception is the renal medulla where osmolality may
exceed 1 osmol/kgH2O. A number of genes have been described whose
expression is upregulated by hypertonic stress in renal medullary cells both
in vitro and in vivo. Most are regulated by activation or synthesis of the
tonicity-responsive transcription factor, TonEBP/NFAT5, and its subsequent
interaction with its cognate cis-acting element, the tonicity
enhancer element/osmotic response element (TonE/ORE; reviewed in Ref.
18).
Cyclooxygenases (COX) are oxidoreductases that catalyze the conversion of
membrane arachidonic acid to PGH2, a precursor of all
prostaglandins, thromboxanes, and prostacyclins
(39). There are at least two
[and perhaps more (6)] isoforms
of COX; COX-1 is constitutively and nearly ubiquitously expressed, whereas the
inducible COX-2 isoform is primarily expressed in kidney and brain. COX-2, as
a key mediator of inflammation, may be upregulated by a variety of cell
activators, including mitogens, hormones, and environmental stressors
(3,
21). Although ambient tonicity
has long been known to influence prostaglandin synthesis in the renal medulla
(11,
12) and gastrointestinal tract
(2,
26), the ability of
hypertonicity to increase expression of COX-2 was first noted in liver
macrophages (51). In the
kidney medulla, upregulated COX-2 (but not COX-1) expression was described in
rodent models of chronic salt loading and water restriction
(48,
49); in vitro, experimental
hypertonic stress correspondingly increased COX-2 but not COX-1 expression in
a collecting duct cell line
(47,
48).
The signaling mechanism through which hypertonicity increases COX-2
expression is of great interest. Yang et al.
(47) observed MAPK dependence
of this phenomenon in cultured cells derived from the inner medullary
collecting duct; specifically, p38, ERK, and JNK axes were all implicated,
either pharmacologically or through a dominant negative approach. In renal
medullary interstitial cell and cortical thick ascending limb models (perhaps
most consistent with the in vivo pattern of renal COX-2 expression; see Ref.
20), tonicity also regulated
COX-2 expression but did so in an NF-
B-dependent fashion
(7,
19).
In an unbiased screen, we identified COX-2 as one of the genes most
prominently upregulated by hypertonicity in the renal medullary mIMCD3 cell
model (41). Because other
tonicity-inducible phenomena are potentially dependent on transactivation of
the EGF receptor (EGFR) kinase (e.g., Refs.
24,
35, and
38) and because at least
partial dependence on the EGFR kinase effector, ERK, had previously been
reported for tonicity-inducible COX-2 expression in this epithelial cell model
(47), we investigated the role
of the EGFR kinase in tonicity-dependent COX-2 expression.
 |
MATERIALS AND METHODS
|
---|
Cell culture conditions and reagents. mIMCD3
(34), 3T3, Madin-Darby canine
kidney (MDCK), and Chinese hamster ovary (CHO) cells were maintained and
passaged in DMEM-F-12 medium supplemented with 10% FBS, as previously
described (8). Cells were
treated after achieving confluence, and supplemental solute was applied at
200 mosM (200 mM urea vs. 100 mM NaCl). All reagents were purchased from
Sigma unless otherwise specified. The following pharmacological inhibitors
were used: AG-1295 (100 nM-1 µM; Calbiochem); AG-1478 (100 nM; Calbiochem);
PD-153035 (100 nM);
N-{DK-[2-(hydroxyaminocarbonyl)methyl]-4-methyl-pentanoyl}-L-3-(2'-naphthyl)-alanyl-L-alanine
2-aminoethyl-amide (TAPI; 310 µM); doxycycline (100 µM); PD-98059
(50 µM); and U-0126 (10 µM). Inhibitors were applied 30 min before
solute or ligand treatment, unless otherwise indicated; all inhibitors were
present for the duration of the solute or ligand treatment interval
(additional 5 min-16 h, depending on assay).
Biochemical and molecular biological assays. Immunoblot analysis
was performed as previously described
(8,
50) using anti-COX-2 primary
antibody (no. 160106; Cayman Chemical) at 1:1,000 and goat anti-rabbit
horseradish peroxidase-conjugated secondary antibody (Pierce) at 1:4,000
dilution. Anti-phosphorylated (P)-ERK (recognizing phosphorylated
Thr202/Tyr204 of ERK1/2), anti-P-JNK (recognizing
phosphorylated Thr183/Tyr185 of JNK1/2), anti-P-p38
(recognizing phosphorylated Thr180/Tyr182 of p38), and
anti-P-EGFR (recognizing phosphorylated Tyr1068) were purchased
from Cell Signaling Technologies and used in accordance with the
manufacturer's directions; 60 kDa anti-heat shock protein (HSP60) was from
Santa Cruz Biotechnologies. Anti-phosphokinase immunoblots were controlled
with subsequent or parallel immunoblotting with the corresponding anti-kinase
antibody. In no instance did kinase expression change during the brief
intervals (030 min) over which kinase-dependent events were explored.
Stable transfection and luciferase reporter gene analyses were performed as
previously described (9) using
sequences from 724 to +7 of the murine COX-2 promoter subcloned into
pXP2 (43). Briefly, mIMCD3
cells were transfected with the indicated plasmid via lipofection and
subjected to selection pressure with G418. A pool of clones was generated in
this fashion and used in aggregate over several passages with equivalent
results in each passage. As the plasmid was integrated, there was no
normalization for transfection efficiency. In transient transfection
experiments performed in parallel, the degree of induction by hypertonicity
was less pronounced (data not shown), consistent with the nature of the COX-2
minimal promoter (5). Induction
was more apparent after normalization for cotransfected
-galactosidase
reporter gene; however, normalization of studies of this sort via
cotransfection is problematic because of a general transcriptional inhibitory
effect of hypertonicity (e.g., see Ref.
41). Still other
"housekeeping" genes, such as actin, are immediate-early genes and
are susceptible to the nonphysiological superinduction
(15) that accompanies a
tonicity-dependent decrement in protein synthesis (Ref.
10 and references therein).
Depicted data are means ± SE of at least three separate experiments
(see legends for Figs. 1,
2,
3,
4,
5,
6,
7,
8,
9), with the exception of
immunoblot data wherein a representative figure is shown. Statistical
significance was ascribed to P < 0.05 via t-test
(VassarStats;
http://vassun.vassar.edu/~lowry/VassarStats.html).
For RNase protection assay to detect COX-2 mRNA, murine kidney
poly(A)+ mRNA was subjected to RT-PCR using primers COX-1411
(5'-TGTACAAGCAGTGGCAAAGG-3') and COX-1726
(5'-GCTCGGCTTCCAGTATTGAG-3') to generate a 316-bp partial cDNA,
which was T/A-subcloned into pCR4. The resultant plasmid was confirmed by
sequencing (Vollum Institute for Advanced Biomedical Research, Oregon Health
and Science University); clone CT005 exhibited identity with murine COX-2 in
BLAST analysis
(http://www.ncbi.nlm.nih-.gov/BLAST/).
This plasmid was linearized with NotI, and transcribed with T3 RNA
polymerase to generate a specific antisense COX-2 riboprobe. ELISA for
PGE2 production (R&D Systems) was performed according to the
manufacturer's directions, using 10-fold dilutions of cell-conditioned
medium.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1. Hypertonic NaCl increases cyclooxygenase (COX)-2 mRNA expression. Effect of
the indicated concentration of supplemental NaCl on COX-2 mRNA abundance at 6
and 24 h of treatment, as assessed via RNase protection assay in renal
medullary mIMCD3 cells. Open arrowhead, COX-2-protected antisense riboprobe;
filled arrowhead, actin control; P, undigested probe-only lane. Figure is
representative of 23 experiments (depending on condition).
|
|

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 2. Pharmacological inhibitors of the EGF receptor (EGFR) kinase block
tonicity-dependent COX-2 expression at the mRNA and protein levels. Effect of
control treatment (C) or supplemental NaCl (N; 100 mM x 6 h) on COX-2
mRNA (A) or protein (B) abundance in the presence or absence
of pretreatment (100 nM x 30 min) with the EGFR kinase inhibitors
PD-153035 (+PD) or AG-1478 (+AG), as assessed via RNase protection assay
(A) or anti-COX-2 immunoblot (B) in renal medullary mIMCD3
cells. Open arrowhead, COX-2-protected antisense riboprobe (A) or
immunoreactive COX-2; filled arrowhead, actin control (A). P,
undigested probe-only lane. C: effect of EGF (10 nM) or hypertonic
stress (NaCl; 100 mM) for the indicated interval (in min) on tyrosine
phosphorylation (on residue Y1068) of the EGFR, as assessed through
anti-phosphorylated (P)-EGFR immunoblotting. In Figs. 2,
3,
4,
5,
6,
7,
8,
9, the molecular mass (in kDa)
of ladder proteins is depicted on left. Data in A,
B, and C are representative of 23, 3, and 2 such
experiments, respectively (depending on condition).
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3. Hypertonic stress increases reporter gene activity driven by the COX-2
promoter. Reporter gene assay of mIMCD3 cells stably transfected with a
construct encoding the luciferase (Luc) reporter gene driven by 0.7 kb of the
human COX-2 promoter, and then subjected to the indicated solute stress for
the indicated interval, in the presence or absence of the EGFR kinase
inhibitor PD-153035. Data are means ± SE of 34 separate
experiments (depending on condition), with determinations performed in
triplicate for each experiment. Data for each experiment were normalized to
control treatment in the absence of PD-153035. Effect of PD-153035 was not
tested under conditions represented by urea (200 mM) and NaCl (50 and 150 mM).
P < 0.05 with respect to control (*) and with respect to the same
treatment in the absence of PD-153035 ( ).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4. Inhibition of the EGFR kinase blocks tonicity-dependent PGE2
generation. Effect of supplemental NaCl (100 mM x 6 or 16 h) on
PGE2 release in cell culture medium in the presence or absence of
pretreatment (100 nM x 30 min) with PD-153035, as quantitated via
anti-PGE2 RIA in renal medullary mIMCD3 cells. Data are means
± SE of 3 separate experiments, with determinations performed in
triplicate for each experiment. P < 0.05 with respect to control
(*) and with respect to the same treatment in the absence of PD-153035
( ).
|
|

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 5. Inhibition of the EGFR kinase blocks tonicity-dependent phosphorylation of
ERK, but not JNK or p38. Effect of supplemental NaCl (100 mM x 10, 30,
or 360 min) on phosphorylation of ERK, JNK, or p38 in the presence or absence
of pretreatment (100 nM x 30 min) with PD-153035, as quantitated via
anti-P-MAPK immunoblotting; open arrowheads, migration of relevant MAPK;
molecular mass markers are indicated on left. JNK migrated as two
bands at 46 and 54 kDa, consistent with published reports. The band
migrating at 42 kDa on the anti-P-JNK most likely represented nonspecific
binding to activated ERK. Figure is representative of 23 experiments
(depending on condition).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6. Hypertonicity-inducible COX-2 expression is sensitive to inhibition of
MEK1/2. Anti-COX-2 immunoblot depicting effect of control treatment (C) or
treatment with the indicated solutes (N, 100 mM NaCl; M, 200 mM mannitol; U,
200 mM urea) for 6 h and in the presence of the MEK1/2 inhibitors PD-98059 (50
µM) and U-0126 (10 µM). Figure is representative of 2 experiments.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7. Hypertonicity-inducible COX-2 expression is sensitive to inhibition of
metalloproteinases. Anti-COX-2 immunoblot depicting effect of control
treatment (C) or hypertonic NaCl [100 mM NaCl (N)] for 6 h and in the presence
of the metalloproteinase inhibitors
N-{DL-[2-(hydroxyaminocarbonyl)methyl]-4-methyl-pentanoyl}-L-3-(2'-naphthyl)-alanyl-L-alanine
2-aminoethyl-amide (TAPI; 3 and 10 µM) and doxycycline (100 µM; Doxy).
Because DMSO may influence COX-2 expression, the effect of DMSO vehicle (Veh)
alone, in percentages (vol/vol) corresponding to diluent requirements for TAPI
(0.07% for TAPI at 3 µM and 0.2% for TAPI at 10 µM), is also depicted.
Figure is representative of 23 experiments (depending on
condition).
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 8. Hypertonicity-dependent COX-2 regulation is HSP60 independent. Effect of
control treatment or hypertonic stress (100 mM NaCl for the indicated
interval) on HSP60 abundance, as measured by anti-HSP60 immunoblotting of
mIMCD3 whole cell detergent lysates. Figure is representative of 2
experiments.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 9. Tonicity-dependent COX-2 upregulation is absent from an EGFR kinase-null
cell line. A: effect of EGF treatment (10 nM x 5 or 30 min) on
ERK phosphorylation in the EGFR-positive cell lines 3T3 and MDCK and in the
EGFR-null Chinese hamster ovary (CHO) cell line. B: effect of
hypertonic stress (100 mM NaCl x 6 h; N) and urea stress (200 mM x
6 h; U) on COX-2 expression in the EGFR-positive cell lines 3T3 and MDCK and
in the EGFR-null CHO cell line. Figure is representative of 23
experiments (depending on condition).
|
|
 |
RESULTS
|
---|
Consistent with the data of others, hypertonic stress (50150 mM
NaCl) increased COX-2 expression at the mRNA level at 6 and 24 h of treatment,
as assessed via RNase protection assay (Fig
1). There was no effect on control (actin) mRNA expression in
response to these stimuli.
Because we have observed other potentially tonicity-dependent signaling
events to be mediated via transactivation of the EGFR, we determined the
effect of pharmacological inhibition of the EGFR on tonicity-dependent COX-2
expression. Two highly specific and potent EGFR kinase inhibitors, PD-153035
and AG-1478, both dramatically inhibited tonicity-dependent COX-2 mRNA
expression (Fig.
2A).
Because upregulation at the mRNA level in response to hypertonic stress is
frequently nonspecific, a consequence of so-called
"superinduction" in the setting of the inhibition in protein
synthesis that often accompanies hypertonic stress (Ref.
10 and references therein), we
sought to determine the effect on COX-2 expression at the protein level.
Again, consistent with the data of others, hypertonic stress dramatically
increased COX-2 expression at the protein level
(Fig. 2B), suggesting
physiological relevance. Because the degree of cell confluence may influence
signaling events, experiments were performed in parallel using subconfluent
cells with comparable results (data not shown). As in the mRNA studies, both
of the EGFR inhibitors markedly decreased the tonicity-dependent COX-2
upregulation (Fig.
2B).
We sought to confirm that the degree of hypertonicity used in this model
was sufficient to activate the EGFR kinase. Hypertonic NaCl (100 mM) induced
tyrosine phosphorylation of this receptor (on residue Tyr1068) to a
degree comparable to that induced by the bona fide EGFR ligand EGF
(Fig. 2C).
To address the upregulation of COX-2 expression in a more mechanistic
fashion, we examined the effect of hypertonicity on reporter gene activity of
an expression plasmid encoding luciferase and under control of the proximal
0.7 kb (724 to +7, relative to the transcriptional start site) of
the human COX-2 promoter (43).
When stably transfected in mIMCD3 cells, the reporter gene exhibited
approximately fivefold greater activity after 6 h of hypertonic stress (100 mM
NaCl; Fig 3). This effect was
also dose dependent within the range of 50150 mM NaCl. The effect of
urea was much more modest (27% increase) but achieved statistical
significance. The tonicity-dependent upregulation was partially blocked when
cells were pretreated with the EGFR kinase inhibitor PD-153035
(Fig. 3). The effect of the
impermeant solute mannitol was equivalent to that of NaCl in this assay, as
was its sensitivity to PD-153035 (data not shown). Because the most widely
recognized tonicity-responsive enhancer element is TonE, we sought this
element in the COX-2 promoter. Using the reported canonical sequence for TonE
(YGGAANNNYNY; see Ref. 31), we
were unable to identify this cis-acting element in the proximal 0.7
kb of the COX-2 5'-flanking sequence (data not shown).
We assessed PGE2 generation as an index of COX-2 function.
Hypertonic NaCl increased PGE2 release in cell supernatants in a
time-dependent fashion, and this effect was blocked by EGFR kinase inhibition
(Fig. 4). Of note, the large
error bar in the 16-h treatment in the absence of PD-153035 is a consequence
of the variability in maximal upregulation by hypertonicity (i.e., 3-fold vs.
20-fold) in these unnormalized data; in all experiments, the ordinal
relationship was identical.
ERK and JNK have been implicated in COX-2 regulation, particularly in
medullary epithelial cells
(47) where they may function
downstream of EGFR in a signaling cascade. We therefore assessed the effect of
EGFR kinase inhibition on activation of all three of the principal MAPK
families by hypertonic stress. As anticipated and as previously shown in this
model, hypertonicity increased ERK activation as assessed via anti-P-ERK
immunoblotting (Fig. 5). Consistent with our earlier observation
(52), EGFR kinase inhibition
markedly blunted the effect of tonicity on ERK activation. In contrast, there
was virtually no effect of EGFR kinase inhibition on tonicity-dependent JNK or
p38 phosphorylation.
Because ERK appeared to be a principal effector of EGFR in this and other
contexts, we tested the effect of pharmacological inhibition of ERK activation
on tonicity-inducible COX-2 expression. We used two different
mitogen/extracellular signal-regulated kinase (MEK) inhibitors (and inhibitors
of ERK activation), PD-98059 and U-0126, in part to permit discrimination
between the anticipated ERK1/2-dependent phenomenon and a potential
ERK5-dependent phenomenon (23)
recently reported in another model
(17). Both MEK inhibitors
substantially blocked the effect of NaCl on this end point, consistent with a
role for MEK (and hence ERK) activation in tonicity-responsive COX-2
expression. Of note, the inhibitors were equally effective when applied at 50
µM for PD-98059 and 10 µM for U-0126, strongly suggesting that ERK5 was
not playing a major role (23).
Consistent with our observations with tonicity-dependent COX-2 transcription,
the effect of hypertonic mannitol vis-à-vis COX-2 expression was
equivalent to that of equiosmolar NaCl, and this effect was equally sensitive
to MEK inhibition (Fig. 6).
EGFR activation generally occurs via metalloproteinase-dependent cleavage
of an EGF-like ectodomain that then acts in an autocrine or juxtacrine fashion
(reviewed in Ref. 16). To test
this possibility in preliminary fashion in the present context, we
investigated the ability of two metalloproteinase inhibitors to abrogate the
effect of tonicity on COX-2 expression. The metalloproteinase inhibitor TAPI,
which blocks ectodomain cleavage of the EGFR ligand, heparin-binding (HB)-EGF
(28), inhibited
tonicity-dependent COX-2 expression in a dose-dependent fashion, whereas
vehicle exerted no effect (Fig.
7). The nonspecific metalloproteinase inhibitor doxycycline (e.g.,
Refs. 14 and
40) also blocked the effect,
albeit to a lesser extent (consistent with its reported efficacy). We were
unable to use the specific hydroxamate-based metalloproteinase inhibitors
(e.g., ilomastat) because the vehicle concentration required by these
relatively insoluble compounds (i.e., DMSO at 0.52%) was sufficient to
interfere with COX-2 expression (data not shown). In support of our
alternative approach, a recent report documented functional equivalence
between TAPI and a hydroxamate-based inhibitor in at least one context
(42).
HSP60 expression induces COX-2 expression
(4), and hypertonic stress has
been associated with increased expression of HSPs in renal epithelial cells
(10). We investigated the
possibility that HSP60 may mediate the effect of hypertonicity on COX-2
expression. Abundant HSP60 expression was detected in mIMCD3 cells
(Fig. 8); however, this level
was unaffected by hypertonic stress or by the presence of EGFR kinase
inhibitors.
Last, we sought an EGFR-null model in which to test for the presence of
tonicity-dependent signaling. Although the EGFR is nearly ubiquitous among
cultured cell lines, CHO cells reportedly lack this tyrosine kinase
(29). We compared CHO cells
with two additional cell lines known to express the EGFR: 3T3 cells and the
renal epithelial MDCK cell line. We first assessed the ability of EGF to
activate ERK in each cell line. As anticipated, EGF induced a marked increase
in ERK phosphorylation in both the 3T3 and MDCK cells at 5 and 30 min of
treatment but produced no effect in the CHO cells
(Fig. 9A). This
confirmed the EGF nonresponsiveness of the CHO line. With this validated model
in hand, we next assessed the ability of hypertonic stress to upregulate COX-2
expression in each cell line. Similar to the effect in mIMCD3 cells,
hypertonic stress dramatically increased COX-2 expression in both 3T3 and MDCK
cells (Fig. 9B); in
marked contrast, however, there was essentially no effect in the EGFR
kinase-null CHO cells. For comparison, we also determined the effect of the
medullary solute, urea, on COX-2 expression in each of these models. Like
NaCl, urea produced no effect in CHO cells. The urea effect was also much less
prominent than that of hypertonic NaCl in both 3T3 and MDCK cells. These data
were consistent with the relatively modest effect of urea vis-à-vis the
COX-2 promoter (Fig. 3). Of
note, introduction of an expression vector encoding EGFR in CHO cells failed
to recapitulate tonicity-inducible COX-2 expression. We infer that EGFR
expression is necessary but not sufficient in this context; CHO cells may lack
either the EGFR ligand (i.e., HB-EGF) or the relevant ligand-directed
metalloproteinase, both of which are required for an intact signaling
module.
 |
DISCUSSION
|
---|
We extend the observations of Yang et al.
(47), who reported MAPK
dependence of renal medullary epithelial cell COX-2 expression in response to
hypertonic stress. We found that two potent and highly specific inhibitors of
the EGFR kinase blocked tonicity-dependent upregulation of COX-2 mRNA
expression, protein expression, transcription, and PGE2 synthesis.
This signaling event was independent of HSP60 expression, which induces COX-2
in at least one model (4). The
inhibitors of EGFR kinase partially blocked tonicity-dependent ERK activation,
as would be expected from the data of Yang et al.
(47), but failed to
significantly influence JNK or p38 phosphorylation. Pharmacological inhibition
of metalloproteinase action similarly blocked COX-2 expression. Furthermore,
the EGF-unresponsive (and EGFR null; see Ref.
29) CHO cell line failed to
exhibit the tonicity-dependent COX-2 expression evident in the EGF-responsive
3T3, MDCK, and mIMCD3 cell lines. In aggregate, these data strongly suggest
that the EGFR kinase mediates the effect of hypertonicity on COX-2 expression
in the renal medullary cell model and that ectodomain cleavage of an EGFR
ligand may be required.
Although medullary COX-2 expression and action likely play a pivotal role
in renal physiology, particularly in response to dehydration, much of this
effect has been attributed to actions of the medullary interstitial cells and
adjacent cells of the macula densa and cortical thick ascending limb (reviewed
in Ref. 20). Nonetheless,
recent reports have emphasized expression and regulation of COX-2 in other
renal epithelial cells in vitro
(13,
47,
48), particularly in the
context of hypertonic stress
(47,
48).
It is of interest that Yang et al.
(47) did not detect an effect
of the tyrosine kinase inhibitors, tyrphostin-A23 (AG-18) and tyrphostin-A51
(AG-183), on tonicity-dependent COX-2 expression, although they did note an
inhibitory effect of the general tyrosine kinase inhibitor genistein
(47). We, in contrast, found a
profound effect in the mIMCD3 cell line at the mRNA and protein level and at
the level of PGE2 production. The study of Yang et al.
(47) was performed using the
mIMCD-K2 cell line (25),
whereas the present study employed the mIMCD3 line
(34). Tyrphostin-A23 and
tyrphostin-A51 exhibit IC50 for EGFR kinase of 40 µM and
800 nM, respectively, and were applied at 10 µM
(47); it is conceivable that
insufficient cellular levels were achieved, particularly for tyrphostin-A23.
While the present studies were being completed, Guo et al.
(17) reported the EGFR
dependence of COX-2 expression in a rat intestinal epithelial cell model in
response to the peptide hormone gastrin, in further support of this mode of
regulation.
Importantly, these are not the first data implicating a role for the EGFR
in transactivating tonicity-dependent signaling. Rosette and Karin
(35) reported aggregation of,
and signaling by, the EGFR using extreme hypertonic stress in a cultured cell
line, although specific genetic targets of this process were not examined. In
contrast, King et al. (24)
reported activation of the EGFR by osmotic shock in the absence of receptor
dimerization. Sheikh-Hamad and co-workers
(38) described
tonicity-dependent association of the following three proteins: the
osmotically inducible CD9
(36),
1-integrin
(37), and the EGFR ligand
HB-EGF. A related phenomenon was observed recently in normal human renal
tissue (32). Moreover,
expression of HB-EGF appears to be itself osmotically regulated
(1,
27). Interestingly, HB-EGF and
CD9 also interact with A disintegrin and metalloprotease domain 10 (also known
as Kuzbanian), and this metalloproteinase may mediate the ectodomain shedding
and autocrine action of EGFR ligands such as HB-EGF
(46). This ternary association
is enhanced by G protein-coupled receptor activation
(46), a phenomenon that has
not been observed in the context of hypertonic stress.
The EGFR ligand conferring transactivation in the present context is
unknown. Potential ligands, including EGF, amphiregulin, epiregulin,
transforming growth factor-
, and HB-EGF, all exist as precursors with a
single membrane-spanning domain and exhibit autocrine or juxtacrine action
after cleavage by one or more metalloproteinases (reviewed in Ref.
33). Our data using the
metalloproteinase inhibitors TAPI and doxycycline support a role for this
mechanism in tonicity-dependent COX-2 regulation, but they do not permit
discrimination among potential EGFR agonists. Neutralizing antibodies specific
for EGFR and EGFR ligands have seen widespread use in other models, but none
are effective in murine systems; we have thus far been unable to identify a
human renal epithelial cell line suitable for studying this phenomenon.
In our studies, the proximal
0.7 kb of the murine COX-2 promoter was
sufficient to confer tonicity responsiveness to a heterologous reporter gene.
Although lacking a canonical tonicity-responsive TonE element, this gene
region contains several cis-acting elements validated in other
contexts. For example, a cAMP-response element (CRE) is instrumental in the
COX-2 response to endotoxin, as are tandem CCAAT/enhancer-binding protein
sites (22,
30,
43); the CRE site, however, is
also responsive to platelet-derived growth factor
(44), in a JNK-dependent
fashion. An NF-
B binding site was implicated in the COX-2 response to
tumor necrosis factor-
(45). Although most of these
data were acquired in heterologous expression systems, studies have emerged
using more native models. For example, both in cultured medullary interstitial
cells exposed to hypertonicity
(19) and in cultured thick
ascending limb cells exposed to low-salt or low-chloride conditions
(7), the NF-
B site
mediated COX-2 transcriptional induction. Our data clearly support a role for
EGFR kinase signaling in tonicity-dependent upregulation of COX-2 expression
in the well-studied mIMCD3 model; whether this effect requires the CRE [as
might be suggested by earlier data with another agonist of a receptor tyrosine
kinase, PDGF (44)], the
NF-
B element [consistent with the interstitial cell and thick ascending
limb models (19)], or still
another element, it clearly occurs in a TonE-independent fashion. Consistent
with these data, EGFR kinase inhibition failed to influence TonE- and
TonEBP-dependent transcription
(52).
In summary, we have shown that the well-described ERK-dependent
upregulation in COX-2 expression accompanying hypertonic stress in medullary
epithelial cells is mediated via transactivation of the EGFR. The EGFR agonist
mediating this effect and the additional upstream activating events remain
obscure.
 |
DISCLOSURES
|
---|
This work was supported by National Institute of Diabetes and Digestive and
Kidney Diseases Grant DK-52494, the American Heart Association, and the
Department of Veterans Affairs.
 |
ACKNOWLEDGMENTS
|
---|
We thank Dr. H. Herschman for the kind gift of the COX-2 promoter in
pXP2.
 |
FOOTNOTES
|
---|
Address for reprint requests and other correspondence: D. M. Cohen, Mailcode
PP262, Oregon Health & Science Univ., 3314 S. W. US Veterans Hospital Rd.,
Portland, OR 97201 (E-mail:
cohend{at}ohsu.edu).
The costs of publication of this article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
 |
REFERENCES
|
---|
- Asakawa H,
Miyagawa J, Higashiyama S, Goishi K, Hanafusa T, Kuwajima M, Taniguchi N, and
Matsuzawa Y. High glucose and hyperosmolarity increase heparin-binding
epidermal growth factor-like growth factor (HB-EGF) production in cultured
human aortic endothelial cells. Cell Biochem Funct
14: 181186,
1996.[ISI][Medline]
- Assouline G,
Leibson V, and Danon A. Stimulation of prostaglandin output from rat
stomach by hypertonic solutions. Eur J Pharmacol
44: 271273,
1977.[ISI][Medline]
- Bazan NG and
Flower RJ. Medicine: lipid signals in pain control.
Nature 420:
135138, 2002.[ISI][Medline]
- Billack B, Heck
DE, Mariano TM, Gardner CR, Sur R, Laskin DL, and Laskin JD. Induction of
cyclooxygenase-2 by heat shock protein 60 in macrophages and endothelial
cells. Am J Physiol Cell Physiol
283: C1267C1277,
2002.[Abstract/Free Full Text]
- Carey M and
Smale ST. Identification and analysis of distant control regions. In:
Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and
Techniques. Cold Spring Harbor, NY: Cold Spring Harbor
Laboratory, 2000, p. 194,
206207.
- Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS,
and Simmons DL. COX-3, a cyclooxygenase-1 variant inhibited by
acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and
expression. Proc Natl Acad Sci USA
99: 1392613931,
2002.[Abstract/Free Full Text]
- Cheng HF and
Harris RC. Cyclooxygenase-2 expression in cultured cortical thick
ascending limb of Henle increases in response to decreased extracellular ionic
content by both transcriptional and post-transcriptional mechanisms: role of
p38-mediated pathways. J Biol Chem
277: 4563845643,
2002.[Abstract/Free Full Text]
- Cohen DM, Chin
WW, and Gullans SR. Hyperosmotic urea increases transcription and
synthesis of Egr-1 in murine inner medullary collecting duct (mIMCD3) cells.
J Biol Chem 269:
2586525870, 1994.[Abstract/Free Full Text]
- Cohen DM,
Gullans SR, and Chin WW. Urea-inducibility of Egr-1 in murine inner
medullary collecting duct cells is mediated by the serum response element and
adjacent Ets motifs. J Biol Chem
271: 1290312908,
1996.[Abstract/Free Full Text]
- Cohen DM,
Wasserman JC, and Gullans SR. Immediate early gene and HSP70 expression in
hyperosmotic stress in MDCK cells. Am J Physiol Cell
Physiol 261:
C594C601, 1991.[Abstract/Free Full Text]
- Craven PA,
Briggs R, and DeRubertis FR. Calcium-dependent action of osmolality on
adenosine 3', 5'-monophosphate accumulation in rat renal inner
medulla: evidence for a relationship to calcium-responsive arachidonate
release and prostaglandin synthesis. J Clin Invest
65: 529542,
1980.[ISI][Medline]
- Danon A, Knapp
HR, Oelz O, and Oates JA. Stimulation of prostaglandin biosynthesis in the
renal papilla by hypertonic mediums. Am J Physiol Renal Fluid
Electrolyte Physiol 234:
F64F67, 1978.[Free Full Text]
- Ferguson S,
Hebert RL, and Laneuville O. NS-398 upregulates constitutive
cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line.
J Am Soc Nephrol 10:
22612271, 1999.[Abstract/Free Full Text]
- Golub LM, Wolff
M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, and Ciancio S. Further
evidence that tetracyclines inhibit collagenase activity in human crevicular
fluid and from other mammalian sources. J Periodontal
Res 20:
1223, 1985.[ISI][Medline]
- Greenberg ME,
Hermanowski AL, and Ziff EB. Effect of protein synthesis inhibitors on
growth factor activation of c-fos, c-myc, and actin gene transcription.
Mol Cell Biol 6:
10501057, 1986.[ISI][Medline]
- Gschwind A,
Zwick E, Prenzel N, Leserer M, and Ullrich A. Cell communication networks:
epidermal growth factor receptor transactivation as the paradigm for
interreceptor signal transmission. Oncogene
20: 15941600,
2001.[ISI][Medline]
- Guo YS, Cheng
JZ, Jin GF, Gutkind JS, Hellmich MR, and Townsend CM Jr. Gastrin
stimulates cyclooxygenase-2 expression in intestinal epithelial cells through
multiple signaling pathways: evidence for involvement of ERK5 kinase and
transactivation of the epidermal growth factor receptor. J Biol
Chem 277:
4875548763, 2002.[Abstract/Free Full Text]
- Handler JS and
Kwon HM. Transcriptional regulation by changes in tonicity.
Kidney Int 60:
408411, 2001.[ISI][Medline]
- Hao CM, Yull F,
Blackwell T, Komhoff M, Davis LS, and Breyer MD. Dehydration activates an
NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary
interstitial cells. J Clin Invest
106: 973982,
2000.[Abstract/Free Full Text]
- Harris RC and
Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney.
Am J Physiol Renal Physiol 281:
F1F11, 2001.[Abstract/Free Full Text]
- Herschman HR. Prostaglandin synthase 2. Biochim
Biophys Acta 1299:
125140, 1996.[ISI][Medline]
- Inoue H,
Yokoyama C, Hara S, Tone Y, and Tanabe T. Transcriptional regulation of
human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and
phorbol ester in vascular endothelial cells: involvement of both nuclear
factor for interleukin-6 expression site and cAMP response element.
J Biol Chem 270:
2496524971, 1995.[Abstract/Free Full Text]
- Karihaloo A,
O'Rourke DA, Nickel C, Spokes K, and Cantley LG. Differential MAPK
pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis.
J Biol Chem 276:
91669173, 2001.[Abstract/Free Full Text]
- King CR,
Borrello I, Porter L, Comoglio P, and Schles-singer J. Ligand-independent
tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene
product is induced by hyperosmotic shock. Oncogene
4: 1318,
1989.[ISI][Medline]
- Kizer NL, Lewis
B, and Stanton BA. Electrogenic sodium absorption and chloride secretion
by an inner medullary collecting duct cell line (mIMCD-K2). Am J
Physiol Renal Fluid Electrolyte Physiol
268: F347F355,
1995.[Abstract/Free Full Text]
- Knapp HR, Oelz
O, Sweetman BJ, and Oates JA. Synthesis and metabolism of prostaglandins
E2, F2alpha and D2 by the rat gastrointestinal tract. Stimulation
by a hypertonic environment in vitro. Prostaglandins
15: 751757,
1978.[Medline]
- Koh YH, Che W,
Higashiyama S, Takahashi M, Miyamoto Y, Suzuki K, and Taniguchi N. Osmotic
stress induces HB-EGF gene expression via Ca2+/Pyk2/JNK
signal cascades in rat aortic smooth muscle cells. J Biochem
(Tokyo) 130:
351358, 2001.[Abstract]
- Lanzrein M,
Garred O, Olsnes S, and Sandvig K. Diphtheria toxin endocytosis and
membrane translocation are dependent on the intact membrane-anchored receptor
(HB-EGF precursor): studies on the cell-associated receptor cleaved by a
metalloprotease in phorbol-ester-treated cells. Biochem
J 310:
285289, 1995.[ISI][Medline]
- Lin SY, Makino
K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, and Hung MC. Nuclear
localization of EGF receptor and its potential new role as a transcription
factor. Nat Cell Biol 3:
802808, 2001.[ISI][Medline]
- Mestre JR,
Mackrell PJ, Rivadeneira DE, Stapleton PP, Tanabe T, and Daly JM.
Redundancy in the signaling pathways and promoter elements regulating
cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic
cells. J Biol Chem 276:
39773982, 2001.[Abstract/Free Full Text]
- Miyakawa H, Woo
SK, Chen CP, Dahl SC, Handler JS, and Kwon HM. Cis- and trans-acting
factors regulating transcription of the BGT1 gene in response to
hypertonicity. Am J Physiol Renal Physiol
274: F753F761,
1998.[Abstract/Free Full Text]
- Nakamura Y,
Handa K, Iwamoto R, Tsukamoto T, Takahasi M, and Mekada E.
Immunohistochemical distribution of CD9, heparin binding epidermal growth
factor-like growth factor, and integrin alpha3beta1 in normal human tissues.
J Histochem Cytochem 49:
439444, 2001.[Abstract/Free Full Text]
- Prenzel N,
Fischer OM, Streit S, Hart S, and Ullrich A. The epidermal growth factor
receptor family as a central element for cellular signal transduction and
diversification. Endocr Relat Cancer
8: 1131,
2001.[Abstract/Free Full Text]
- Rauchman MI,
Nigam S, Delpire E, and Gullans SR. An osmotically tolerant inner
medullary collecting duct cell line from an SV40 transgenic mouse.
Am J Physiol Renal Fluid Electrolyte Physiol
265: F416F424,
1993.[Abstract/Free Full Text]
- Rosette C and
Karin M. Ultraviolet light and osmotic stress: activation of the JNK
cascade through multiple growth factor and cytokine receptors.
Science 274:
11941197, 1996.[Abstract/Free Full Text]
- Sheikh-Hamad D,
Ferraris JD, Dragolovich J, Preuss HG, Burg MB, and Garcia-Perez A. CD9
antigen mRNA is induced by hypertonicity in two renal epithelial cell lines.
Am J Physiol Cell Physiol 270:
C253C258, 1996.[Abstract/Free Full Text]
- Sheikh-Hamad D,
Suki WN, and Zhao W. Hypertonic induction of the cell adhesion molecule
beta 1-integrin in MDCK cells. Am J Physiol Cell
Physiol 273:
C902C908, 1997.[Abstract/Free Full Text]
- Sheikh-Hamad D,
Youker K, Truong LD, Nielsen S, and Entman ML. Osmotically relevant
membrane signaling complex: association between HB-EGF, beta(1)-integrin, and
CD9 in mTAL. Am J Physiol Cell Physiol
279: C136C146,
2000.[Abstract/Free Full Text]
- Smith WL,
DeWitt DL, and Garavito RM. Cyclooxygenases: structural, cellular, and
molecular biology. Annu Rev Biochem
69: 145182,
2000.[ISI][Medline]
- Suomalainen K,
Sorsa T, Golub LM, Ramamurthy N, Lee HM, Uitto VJ, Saari H, and Konttinen
YT. Specificity of the anticollagenase action of tetracyclines: relevance
to their antiinflammatory potential. Antimicrob Agents
Chemother 36:
227229, 1992.[Abstract]
- Tian W and
Cohen DM. Urea stress is more akin to EGF exposure than to hypertonic
stress in renal medullary cells. Am J Physiol Renal
Physiol 283:
F388F398, 2002.[Abstract/Free Full Text]
- Vincent B,
Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J,
Lopez-Perez E, and Checler F. The disintegrins ADAM10 and TACE contribute
to the constitutive and phorbol ester-regulated normal cleavage of the
cellular prion protein. J Biol Chem
276: 3774337746,
2001.[Abstract/Free Full Text]
- Wadleigh DJ,
Reddy ST, Kopp E, Ghosh S, and Herschman HR. Transcriptional activation of
the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages.
J Biol Chem 275:
62596266, 2000.[Abstract/Free Full Text]
- Xie W and
Herschman HR. Transcriptional regulation of prostaglandin synthase 2 gene
expression by platelet-derived growth factor and serum. J Biol
Chem 271:
3174231748, 1996.[Abstract/Free Full Text]
- Yamamoto K,
Arakawa T, Ueda N, and Yamamoto S. Transcriptional roles of nuclear factor
kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor
alpha-dependent induction of cyclooxygenase-2 in MC3T3E1 cells.
J Biol Chem 270:
3131531320, 1995.[Abstract/Free Full Text]
- Yan Y,
Shirakabe K, and Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates
the transactivation of EGF receptor by G protein-coupled receptors.
J Cell Biol 158:
221226, 2002.[Abstract/Free Full Text]
- Yang T, Huang
Y, Heasley LE, Berl T, Schnermann JB, and Briggs JP. MAPK mediation of
hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary
collecting duct cells. J Biol Chem
275: 2328123286,
2000.[Abstract/Free Full Text]
- Yang T,
Schnermann JB, and Briggs JP. Regulation of cyclooxygenase-2 expression in
renal medulla by tonicity in vivo and in vitro. Am J Physiol Renal
Physiol 277:
F1F9, 1999.[Abstract/Free Full Text]
- Yang T, Singh
I, Pham H, Sun D, Smart A, Schnermann JB, and Briggs JP. Regulation of
cyclooxygenase expression in the kidney by dietary salt intake. Am
J Physiol Renal Physiol 274:
F481F489, 1998.[Abstract/Free Full Text]
- Yang X-Y, Zhang
Z, and Cohen DM. ERK activation by urea in renal inner medullary cells.
Am J Physiol Renal Physiol 277:
F176F185, 1999.[Abstract/Free Full Text]
- Zhang F,
Warskulat U, Wettstein M, Schreiber R, Henninger HP, Decker K, and Haussinger
D. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2
expression in activated rat liver macrophages. Biochem
J 312:
135143, 1995.[ISI][Medline]
- Zhao H, Tian W,
Xu H, and Cohen DM. Urea signaling to immediate-early gene transcription
in renal medullary cells requires transactivation of the epidermal growth
factor receptor. Biochem J 370:
479487, 2003.[ISI][Medline]